CLEVELAND, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO) today announced that it has entered into a $50 million credit facility with the Avenue Venture Opportunities Fund, L.P. The credit agreement, which has a term of three and a half years, includes a first tranche of$20 million at closing, a second tranche of $10 million of committed capital, and an additional accordion option to upsize the credit facility by an additional$20 million upon satisfaction of certain terms and con ...